BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 848436)

  • 1. Acute blood pressure elevation and ventricular fibrillation threshold during coronary occlusion and reperfusion in the dog.
    Blatt CM; Verrier RL; Lown B
    Am J Cardiol; 1977 Apr; 39(4):523-8. PubMed ID: 848436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nitroglycerin on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion.
    Stockman MB; Verrier RL; Lown B
    Am J Cardiol; 1979 Feb; 43(2):233-8. PubMed ID: 104608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between sympathetic neural activity, coronary dynamics, and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion.
    Lombardi F; Verrier RL; Lown B
    Am Heart J; 1983 Jun; 105(6):958-65. PubMed ID: 6858844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and release.
    Axelrod PJ; Verrier RL; Lown B
    Am J Cardiol; 1975 Nov; 36(6):776-82. PubMed ID: 1199933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion.
    Brooks WW; Verrier RL; Lown B
    Cardiovasc Res; 1980 May; 14(5):295-302. PubMed ID: 7388861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericardial prostaglandin biosynthesis prevents the increased incidence of reperfusion-induced ventricular fibrillation produced by efferent sympathetic stimulation in dogs.
    Miyazaki T; Zipes DP
    Circulation; 1990 Sep; 82(3):1008-19. PubMed ID: 2118429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reflex inhibition of renal sympathetic nerve activity during myocardial ischemia mediated by left ventricular receptors with vagal afferents in dogs.
    Thames MD; Abboud FM
    J Clin Invest; 1979 Mar; 63(3):395-402. PubMed ID: 429560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release.
    Corbalan R; Verrier RL; Lown B
    Am Heart J; 1976 Aug; 92(2):223-30. PubMed ID: 941834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
    Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T
    Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute blood pressure elevation on the ventricular fibrillation threshold.
    Verrier R; Calvert A; Lown B; Axelrod P
    Am J Physiol; 1974 Apr; 226(4):893-7. PubMed ID: 4823051
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs.
    Linz D; Wirth K; Ukena C; Mahfoud F; Pöss J; Linz B; Böhm M; Neuberger HR
    Heart Rhythm; 2013 Oct; 10(10):1525-30. PubMed ID: 23851058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alpha-adrenergic receptor stimulation on ventricular electrical properties in the normal canine heart.
    Kowey PR; Verrier RL; Lown B
    Am Heart J; 1983 Mar; 105(3):366-71. PubMed ID: 6187202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digitalis drugs and vulnerability to ventricular fibrillation.
    Brooks WW; Verrier RL; Lown B
    Eur J Pharmacol; 1979 Jul; 57(1):69-78. PubMed ID: 38976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derangements of myocardial metabolism preceding onset of ventricular fibrilliation after coronary occlusion.
    Corday E; Heng MK; Meerbaum S; Lang TW; Farcot JC; Osher J; Hashimoto K
    Am J Cardiol; 1977 May; 39(6):880-9. PubMed ID: 16479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occlusion time dependency of regional noradrenaline release and cardiac arrhythmias during reperfusion of acutely ischaemic heart in the dog in vivo.
    Yamaguchi N; Kimura T; Lamontagne D; de Champlain J; Nadeau R
    Cardiovasc Res; 1990 Aug; 24(8):688-96. PubMed ID: 2224938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of coronary sinus obstruction from primary ischemia-induced ventricular fibrillation in the dog.
    Kralios AC; Anderson FL; Kralios FA
    Am Heart J; 1993 Apr; 125(4):987-95. PubMed ID: 8465771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs.
    Végh A; Parratt JR
    Cardiovasc Res; 2002 Jul; 55(1):53-63. PubMed ID: 12062708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clonidine on vulnerability to fibrillation in the normal and ischemic canine ventricle.
    Rotenberg FA; Verrier RL; Lown B; Sole MJ
    Eur J Pharmacol; 1978 Jan; 47(1):71-9. PubMed ID: 618732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed cardioprotective effects of exercise in dogs are aminoguanidine sensitive: possible involvement of nitric oxide.
    Babai L; Szigeti Z; Parratt JR; Végh A
    Clin Sci (Lond); 2002 Apr; 102(4):435-45. PubMed ID: 11914106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of acute hyperinsulinemia to alter blood pressure is not due to baroreceptor feedback.
    Richey JM; Poulin RA; Buchanan TA; Galperin E; Moore DM; Bergman RN
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):405-13. PubMed ID: 10232501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.